|
Fucithalmic
Viscous eye-drops
Fucithalmic is a sterile 1%
aqueous sustained-release formulation of fusidic acid, preserved with
benzalkonium chloride.
Properties
Fucithalmic is active against
Staphylococci, Streptococci, Neisseria, Haemophilus, Moraxella and
Corynebacteria.
The sustained-release formulation
of Fucithalmic ensures a prolonged contact with the conjunctival sac. A
twice-daily application provides sufficient concentrations in all relevant
tissues of the eye. Fucithalmic penetrates well into the aqueous humour.
Indications
Bacterial eye infections caused
by susceptible organisms in conjunctivitis, blepharitis, sty, keratitis,
dacryocystitis and in connection with removal of foreign bodies.
Dosage
One drop to be instilled into the
eye twice daily. Treatment should be continued for at least two days after
the eye appears normal.
Contra-indications
Hypersensitivity to any component
Precautions
Should not be used when contact
lenses are being worn.
Pregnancy and lactation
There is inadequate evidence of
safety in human pregnancy. Animal studies and many years of clinical
experience have suggested that fusidic acid is devoid of teratogenic
effects. Safety in nursing mothers has not been established.
Side-effects
Transient stinging may occur.
Fucithalmic has a very low allergenic potential.
Drug interaction
Not relevant
Incompatibilities
Fucithalmic is a ready-for-use
preparation and should, therefore not be mixed with other ingredients or
preparations.
Storage
Store at controlled room
temperature ( 15°C - 25°C )
Discard 30 days after opening. |
